UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
EndowmentPosition in NBIX — Neurocrine Biosciences Inc
CIK 1019231
AUSTIN, TX
Position in NBIX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,212,139
-$1,163,923 QoQ
Shares Held
7,192
-60.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#373
of 768 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO holds $8,051,073 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
9,328 | $5,054,190 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
7,192 | $1,212,139 | |
| 3 | VTRS |
Viatris Inc
|
54,107 | $859,219 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
18,186 | $746,171 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
1,184 | $131,352 | |
| 6 | ZTS |
Zoetis Inc.
|
353 | $25,366 | |
| 7 | HROW |
Harrow, Inc.
|
533 | $22,636 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,212,139 | 7,192 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,376,062 | 18,036 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,587,928 | 11,196 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,144,164 | 15,274 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||